Haematologica (Jun 2024)
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results
- Shinya Rai,
- Won Seog Kim,
- Kiyoshi Ando,
- Ilseung Choi,
- Koji Izutsu,
- Norifumi Tsukamoto,
- Dai Maruyama,
- Kunihiro Tsukasaki,
- Junya Kuroda,
- Jun Ando,
- Michihiro Hidaka,
- Youngil Koh,
- Hisashi Kato,
- Toshiki Uchida,
- Deok Hwan Yang,
- Kenji Ishitsuka,
- Kenichi Ishizawa,
- Jin Seok Kim,
- Hong Ghi Lee,
- Hironobu Minami,
- Hyeon Seok Eom,
- Mitsutoshi Kurosawa,
- Jae Hoon Lee,
- Jong Seok Lee,
- Won Sik Lee,
- Hirokazu Nagai,
- Takero Shindo,
- Dok Hyun Yoon,
- Shinichiro Yoshida,
- Mireille Gillings,
- Hiroshi Onogi,
- Kensei Tobinai
Affiliations
- Shinya Rai
- Department of Hematology and Rheumatology, Faculty of Medicine, Kindai University, Osaka-Sayama
- Won Seog Kim
- Division of Hematology Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine, Seoul
- Kiyoshi Ando
- Hematology and Oncology, Tokai University Hospital, Isehara
- Ilseung Choi
- Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka
- Koji Izutsu
- Department of Hematology, National Cancer Center Hospital, Tokyo
- Norifumi Tsukamoto
- Oncology Center, Gunma University Hospital, Maebashi
- Dai Maruyama
- Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo
- Kunihiro Tsukasaki
- Hematology, International Medical Center, Saitama Medical University, Saitama
- Junya Kuroda
- Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto
- Jun Ando
- Department of Hematology, Juntendo University School of Medicine, Tokyo
- Michihiro Hidaka
- Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto
- Youngil Koh
- Internal Medicine, Seoul National University Hospital, Seoul
- Hisashi Kato
- Hematology and Oncology, Osaka University Graduate School of Medicine, Suita
- Toshiki Uchida
- Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya
- Deok Hwan Yang
- Hematology-Oncology, Chonnam National University Hwasun Hospital, Chonnam National Medical School, Gwangju
- Kenji Ishitsuka
- Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima
- Kenichi Ishizawa
- Third Internal Medicine, Yamagata University Hospital, Yamagata
- Jin Seok Kim
- Division of Hematology, Department of Internal Medicine, Yonsei University College of Medicine, Severance Hospital, Seoul
- Hong Ghi Lee
- Hematology and Oncology, Konkuk University Medical Center, Seoul
- Hironobu Minami
- Medical Oncology/Hematology, Kobe University Hospital, Kobe
- Hyeon Seok Eom
- Center for Hematologic Malignancy, National Cancer Center, Goyang-si
- Mitsutoshi Kurosawa
- Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo
- Jae Hoon Lee
- Division of Hematology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon
- Jong Seok Lee
- Division of Hematology-Oncology, Seoul National University Bundang Hospital, Gyeonggi
- Won Sik Lee
- Internal Medicine, Inje University Busan Paik Hospital, Busan
- Hirokazu Nagai
- Department of Hematology, National Hospital Organization Nagoya Medical Center, Nagoya
- Takero Shindo
- Hematology and Oncology, Kyoto University Hospital, Kyoto
- Dok Hyun Yoon
- Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul
- Shinichiro Yoshida
- Hematology, National Hospital Organization Nagasaki Medical Center, Omura
- Mireille Gillings
- HUYABIO International, San Diego, CA
- Hiroshi Onogi
- Huya Japan GK, Tokyo
- Kensei Tobinai
- Department of Hematology, National Cancer Center Hospital, Tokyo
- DOI
- https://doi.org/10.3324/haematol.2023.283992
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
